{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hypoalphalipoproteinemia-primary-2-intermediate","columns":[{"gene":"","key":"population-fafcc43178db898486c9","label":"Hypoalphalipoproteinemia, primary, 2, intermediate","mondoId":"MONDO:0859238","onsetQualifier":null,"originColumnKey":"MONDO:0859238/OMIM:619836","originalViews":[{"key":"MONDO:0859238/OMIM:619836","label":"Hypoalphalipoproteinemia, primary, 2, intermediate","scopeLabel":"OMIM:619836","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["404f6a3df520f30f0b9cdb1c180e540281f90d4de5677951af05233bf1b3469b","57d2e2948922a76855657cd343f896d9a2c2806a6b6ac7dde8850e25abf22aa9"],"recordQualifiers":{},"scopeLabel":"OMIM:619836","sourceIds":["OMIM:619836"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-fafcc43178db898486c9"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0031799","HP:0003233"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":2,"sourceGroups":{"published":2}},"features":[{"hpoId":"HP:0031799","label":"Decreased circulating apolipoprotein A-I concentration","primary":true},{"hpoId":"HP:0003233","label":"Decreased circulating HDL-C concentration","primary":true}],"ledeHtml":"","mondoId":"MONDO:0859238","node":{"canonicalSlug":"hypoalphalipoproteinemia-primary-2-intermediate","comparisons":[{"documentSha256":"a535c5db3575800f7c716620a5f4feeb90d8ad8fe913e71102989a6e0b2b7c90","key":"legacy-hypoalphalipoproteinemia-primary-2","kind":"legacy","label":"hypoalphalipoproteinemia, primary, 2","memberIds":["MONDO:0032766","MONDO:0859238"],"mondoId":"MONDO:0032766","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hypoalphalipoproteinemia-primary-2.a535c5db3575800f7c716620a5f4feeb90d8ad8fe913e71102989a6e0b2b7c90.json"}],"contexts":[],"lifecycle":"active","narrative":null,"ownColumnKeys":["population-fafcc43178db898486c9"],"publication":"published","relationships":[{"kind":"parent","label":"hypoalphalipoproteinemia, primary, 2","mondoId":"MONDO:0032766","slug":"hypoalphalipoproteinemia-primary-2"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26677"}],"translation":"published"},"records":[{"frequencyKind":"reported","key":"404f6a3df520f30f0b9cdb1c180e540281f90d4de5677951af05233bf1b3469b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:619836","disease_name":"Hypoalphalipoproteinemia, primary, 2, intermediate","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003233","is_excluded":false,"label":"Decreased circulating HDL-C concentration","onset_id":null,"reference":"PMID:2512329","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"57d2e2948922a76855657cd343f896d9a2c2806a6b6ac7dde8850e25abf22aa9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:619836","disease_name":"Hypoalphalipoproteinemia, primary, 2, intermediate","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0031799","is_excluded":false,"label":"Decreased circulating apolipoprotein A-I concentration","onset_id":null,"reference":"PMID:2512329","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[],"sharedSources":[],"slug":"hypoalphalipoproteinemia-primary-2-intermediate","sourceDocuments":[],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"hypoalphalipoproteinemia, primary, 2, intermediate"},"schemaVersion":1}
